Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moonis, M.
Right arrow Articles by Pollen, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moonis, M.
Right arrow Articles by Pollen, D. A.
Related Collections
Right arrow MTI
Right arrow Frontotemporal dementia
Right arrowRelated Article
NEUROLOGY 2005;65:323-325
© 2005 American Academy of Neurology
Brief Communications

Familial Alzheimer disease: Decreases in CSF Aß42 levels precede cognitive decline

M. Moonis, MD, J. M. Swearer, PhD, M. P. E. Dayaw, MD, P. St. George-Hyslop, MD, FRCP(C), E. Rogaeva, PhD, T. Kawarai, MD and D. A. Pollen, MD

From the Department of Neurology (Drs. Moonis, Swearer, Dayaw, and Pollen), University of Massachusetts Medical School, Worcester, MA; and Centre for Research in Neurodegenerative Diseases (Drs. St. George-Hyslop, Rogaeva, and Kawarai), Department of Medicine, University of Toronto and Toronto Western Hospital Research Institute, Movement Disorders Centre (Dr. St. George-Hyslop), Toronto Western Hospital Research Institute, Toronto Western Hospital and University of Toronto, and Division of Neurology (Drs. St. George-Hyslop and Rogaeva), Department of Medicine, University of Toronto, Ontario, Canada.

Address correspondence and reprint requests to Dr Pollen, Department of Neurology, University of Massachusetts Medical School, 55 Lake Ave. N., Worcester, MA 01655; e-mail: pollend{at}ummhc.org

CSF amyloid ß-peptide 42 (Aß42) levels in presymptomatic subjects with pathogenic mutations in the PS1 gene are significantly lower than in an age-matched control group. Consequently, in these subjects, there is a window of opportunity estimated as at least 4 to 12 years to evaluate the ability of any putative prophylactic therapy to decrease, arrest, or reverse abnormalities in Aß42 metabolism many years before clinical symptoms of Alzheimer disease are otherwise likely to occur.

Received February 12, 2005. Accepted in final form April 12, 2005.


Related Article

July 26 Highlights
Neurology 2005 65: 184-185. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Epidemiol RevHome page
J. J. Jalbert, L. A. Daiello, and K. L. Lapane
Dementia of the Alzheimer Type
Epidemiol. Rev., November 1, 2008; 30(1): 15 - 34.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, et al.
Biochemical markers in persons with preclinical familial Alzheimer disease
Neurology, July 8, 2008; 71(2): 85 - 92.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. L. Cummings, R. Doody, and C. Clark
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Neurology, October 16, 2007; 69(16): 1622 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
G. Li, I. Sokal, J. F. Quinn, J. B. Leverenz, M. Brodey, G. D. Schellenberg, J. A. Kaye, M. A. Raskind, J. Zhang, E. R. Peskind, et al.
CSF tau/A{beta}42 ratio for increased risk of mild cognitive impairment: A follow-up study
Neurology, August 14, 2007; 69(7): 631 - 639.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. E. Klunk, J. C. Price, C. A. Mathis, N. D. Tsopelas, B. J. Lopresti, S. K. Ziolko, W. Bi, J. A. Hoge, A. D. Cohen, M. D. Ikonomovic, et al.
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
J. Neurosci., June 6, 2007; 27(23): 6174 - 6184.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. R. Peskind, G. Li, J. Shofer, J. F. Quinn, J. A. Kaye, C. M. Clark, M. R. Farlow, C. DeCarli, M. A. Raskind, G. D. Schellenberg, et al.
Age and Apolipoprotein E*4 Allele Effects on Cerebrospinal Fluid beta-Amyloid 42 in Adults With Normal Cognition.
Arch Neurol, July 1, 2006; 63(7): 936 - 939.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.